Results 1 to 10 of about 662 (116)
Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
New England Journal of Medicine, 2021 Several cases of unusual thrombotic events and thrombocytopenia have developed after vaccination with the recombinant adenoviral vector encoding the spike protein antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, AstraZeneca). More data were needed on the pathogenesis of this unusual clotting disorder.We assessed
Kang-Yiu, Lai +2 more
openaire +6 more sources
Postvaccinal Encephalitis after
Annals of Neurology, 2021 The global SARS‐CoV‐2 pandemic has contributed to more than 163 million confirmed infections and 3.3 million deaths worldwide. The severity of the pandemic has led to an unprecedented effort to develop multiple effective vaccines. Due to excellent safety and efficacy data from clinical trials, several vaccines were approved.
Frédéric Zuhorn +4 more
openaire +2 more sources
Thromboses of major arteries and ChAdOx1 nCov-19 vaccination [PDF]
Neurological Research and Practice, 2021 AbstractThis correspondence discussed on published article on “thromboses of major arteries and ChAdOx1 nCov-19 vaccination”.
Rujittika Mungmunpuntipantip +1 more
openaire +3 more sources
Haemophagocytic lymphohistiocytosis after ChAdOx1 nCoV-19 vaccination [PDF]
Journal of Clinical Pathology, 2021 We report three cases of haemophagocytic lymphohistiocytosis (HLH) following the ChAdOx1 Astrazeneca vaccine. HLH is a rare but often fatal dysregulated hyperimmune response that clinically resembles sepsis.1 It is classified as either familial, with known genetic defects in lymphocyte cytotoxicity identified (such as PRF1 or UNC13D mutations) or ...
Luke Attwell +4 more
openaire +2 more sources
Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
BMJ Case Reports, 2022 Adverse events occurring after SARS-CoV-2 vaccination have been reported and are the subject of ongoing research. We present the case of a young woman with fully reversible radiculomyelitis, which happened after the first dose of the ChAdOx1 nCOVID-19 vaccine.
Rossella Spataro +2 more
openaire +5 more sources
Vaccines, 2023 This study investigated the immunogenicity of, and reactogenicity to, the ChAdOx1 nCoV-19 vaccine according to pre-existing adenovirus immunity. Individuals scheduled for COVID-19 vaccination were prospectively enrolled in a tertiary hospital with 2400 ...
Jinnam Kim +11 more
doaj +1 more source
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
New England Journal of Medicine, 2021 We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The patients were health care workers who were 32 to 54 years of age.
Nina H. Schultz +10 more
openaire +4 more sources
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV [PDF]
JCI Insight, 2022 La duración de la protección contra la infección por SARS-CoV-2 en personas que viven con VIH (PWH) después de la vacunación no está clara. En un subestudio de la fase II/III del ensayo COV002 (NCT04400838), 54 participantes masculinos VIH+ en terapia antirretroviral (cargas virales indetectables, células T CD4+ > 350 células/μL) recibieron 2 dosis de ...
Ane Ogbe +57 more
openaire +7 more sources
Vaccines, 2021 Despite limited data on safety and immunogenicity, heterologous prime-boost vaccination is currently recommended for individuals with ChAdOx1 nCoV-19 prime immunization in certain age groups.
Louise Benning +15 more
doaj +1 more source
ADEM after ChAdOx1 nCoV-19 vaccine: A case report [PDF]
Multiple Sclerosis Journal, 2021 Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system (CNS), clinically defined by an acute polyfocal neurological syndrome usually with monophasic course. ADEM often occurs after infections, but 5%–10% of cases are preceded by vaccinations.
Rinaldi V. +4 more
openaire +3 more sources